Systemic Lupus Erythematosus and Accelerated Aging
Recruiting · NCT05698173 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital, Bordeaux
View the official record on ClinicalTrials.gov →Interventions studied
blood sample
What this trial is about
The study aims at evaluating the phenomena of immune system aging in patients with Systemic lupus erythematosus.
Who can take part
Age range
18 Years to 60 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- male or female;
- age between 18 and 60 years;
- Lupus patient : diagnosis of systemic lupus erythematosus according to ACR or SLICC criteria;
- being affiliated to health insurance;
- willing to participate and to sign informed consent.
Exclusion criteria
- pregnant or breastfeeding women;
- persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent
Where it is running
1 location listed.
- CHU de Bordeaux - Médecine Interne et Immunologie Clinique - Bordeaux, France